UnitedHealth Group Incorporated (NYSE:UNH) Expected to Post Earnings of $5.40 Per Share

Wall Street analysts expect UnitedHealth Group Incorporated (NYSE:UNHGet Rating) to announce earnings per share (EPS) of $5.40 for the current fiscal quarter, Zacks Investment Research reports. Eight analysts have provided estimates for UnitedHealth Group’s earnings. The highest EPS estimate is $5.88 and the lowest is $5.19. UnitedHealth Group reported earnings per share of $5.31 during the same quarter last year, which indicates a positive year-over-year growth rate of 1.7%. The business is scheduled to issue its next quarterly earnings results before the market opens on Monday, January 1st.

On average, analysts expect that UnitedHealth Group will report full-year earnings of $21.69 per share for the current fiscal year, with EPS estimates ranging from $21.42 to $22.37. For the next fiscal year, analysts anticipate that the company will post earnings of $24.76 per share, with EPS estimates ranging from $24.25 to $25.65. Zacks’ earnings per share averages are an average based on a survey of research analysts that that provide coverage for UnitedHealth Group.

UnitedHealth Group (NYSE:UNHGet Rating) last posted its earnings results on Wednesday, January 19th. The healthcare conglomerate reported $4.48 EPS for the quarter, beating the Zacks’ consensus estimate of $4.30 by $0.18. The firm had revenue of $73.74 billion for the quarter, compared to the consensus estimate of $72.86 billion. UnitedHealth Group had a net margin of 6.01% and a return on equity of 25.11%. The company’s revenue was up 12.6% on a year-over-year basis. During the same period last year, the firm posted $2.52 EPS.

A number of research firms recently commented on UNH. Truist Financial increased their target price on shares of UnitedHealth Group from $575.00 to $610.00 in a research report on Thursday, April 7th. Edward Jones began coverage on shares of UnitedHealth Group in a research note on Monday, January 10th. They set a “buy” rating for the company. Sanford C. Bernstein increased their price target on shares of UnitedHealth Group from $508.00 to $564.00 in a research note on Tuesday, January 11th. StockNews.com began coverage on shares of UnitedHealth Group in a research note on Thursday, March 31st. They set a “strong-buy” rating for the company. Finally, The Goldman Sachs Group initiated coverage on shares of UnitedHealth Group in a research note on Tuesday, December 14th. They set a “buy” rating and a $535.00 price target for the company. Two research analysts have rated the stock with a hold rating, twenty-one have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus price target of $507.96.

NYSE UNH opened at $537.44 on Tuesday. The company has a debt-to-equity ratio of 0.56, a current ratio of 0.79 and a quick ratio of 0.79. The firm’s fifty day moving average price is $494.41 and its 200 day moving average price is $468.66. The company has a market capitalization of $505.68 billion, a price-to-earnings ratio of 29.73, a price-to-earnings-growth ratio of 1.70 and a beta of 0.88. UnitedHealth Group has a 12 month low of $374.03 and a 12 month high of $548.97.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 22nd. Investors of record on Monday, March 14th were paid a $1.45 dividend. This represents a $5.80 annualized dividend and a dividend yield of 1.08%. The ex-dividend date of this dividend was Friday, March 11th. UnitedHealth Group’s dividend payout ratio (DPR) is 32.08%.

In other UnitedHealth Group news, Director Richard T. Burke sold 4,000 shares of the firm’s stock in a transaction dated Tuesday, March 22nd. The shares were sold at an average price of $511.14, for a total transaction of $2,044,560.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Richard T. Burke sold 5,000 shares of the firm’s stock in a transaction dated Wednesday, February 16th. The shares were sold at an average price of $476.72, for a total transaction of $2,383,600.00. The disclosure for this sale can be found here. Insiders have sold a total of 23,000 shares of company stock valued at $11,123,890 over the last 90 days. 0.55% of the stock is currently owned by insiders.

Several hedge funds and other institutional investors have recently modified their holdings of the company. Outfitter Financial LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth approximately $25,000. Blue Bell Private Wealth Management LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth approximately $29,000. Advocacy Wealth Management Services LLC boosted its position in shares of UnitedHealth Group by 75.8% in the first quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock worth $30,000 after acquiring an additional 25 shares during the last quarter. Cascade Investment Advisors Inc. boosted its position in shares of UnitedHealth Group by 100.0% in the first quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 30 shares during the last quarter. Finally, Tortoise Investment Management LLC boosted its position in shares of UnitedHealth Group by 54.8% in the fourth quarter. Tortoise Investment Management LLC now owns 65 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 23 shares during the last quarter. Institutional investors and hedge funds own 86.07% of the company’s stock.

UnitedHealth Group Company Profile (Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Read More

Get a free copy of the Zacks research report on UnitedHealth Group (UNH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.